Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial
β Scribed by Gennaro D'Amico; Flavia Politi; Alberto Morabito; Adele D'Antoni; Daniela Guerrera; Gandolfo Giannuoli; Mario Traina; Giovanni Vizzini; Linda Pasta; Luigi Pagliaro
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 97 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Because of its ability to decrease portal pressure, azygos blood flow, and postprandial splanchnic hyperemia, octreotide administration could be effective in reducing early rebleeding in patients undergoing endoscopic variceal sclerotherapy (EVS). We report the results of a trial comparing EVS + oct
## Abstract **Objectives** To compare, in a doubleβblind, randomized, prospective study, the clinical improvement of hyperpigmentation in 30 patients with melasma using hydroquinone or skin whitening complex topically on one side of the face vs. a placebo cream on the other. The study was performed
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex